Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alaunos Therapeutics, Inc.ZIOP · Entity 8339 | Director | December 29, 2017 | January 03, 2018 |
| BRANDYWINE REALTY TRUSTBDN · Entity 5445 | Director | December 14, 2020 | December 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alaunos Therapeutics, Inc.
Report date December 29, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 156,446 |
Ending reported balance
After 2017-12-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-12-29 · Grant · Acquired 17,258 · Balance 163,328 F1: 17,258 shares vest on 12/29/2018. Row 2 · 2017-12-30 · Tax withholding · Disposed 6,882 · Balance 156,446 F2: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. |
Filing footnotes · ownership attribution and instrument terms
F1: 17,258 shares vest on 12/29/2018.
F2: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
BRANDYWINE REALTY TRUST
Report date December 14, 2020 · Filed December 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 75,689 |
Reported balance
After 2020-12-14 transaction · row 1
1 source rowRow 1 · 2020-12-14 · Sale · Disposed 8,598 · Balance 75,689 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 15, 2020 21:58 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | SaleCommon Shares of Beneficial Interest | 8,598 | $11.89 | $102,230.22 |
DisclosureSEC source: 0001209191-20-063517 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,689 Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:01 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | GrantCommon Shares of Beneficial Interest | 10,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031796 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,287 F1 · security: These shares reflect the $95,000 Annual Trustee share award, the number of shares of which is calculated based upon a closing price on 05/20/2020 of $9.45. Shares vested immediately upon grant. F2 · balance_after: The amount reflects a 2,999 share decrease from the Reporting Person's previous ending balance to correct an error. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:09 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | GrantCommon Shares of Beneficial Interest | 6,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032679 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,233 F1 · security: These shares reflect the $95,000 Annual Trustee share award, the number of shares of which is calculated based upon a closing price on 05/22/2019 of $15.01. Shares vested immediately upon grant. Read SEC document |
| May 23, 2018 Filed May 24, 2018 19:26 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | GrantCommon Shares of Beneficial Interest | 5,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032945 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,904 F1 · security: These shares reflect the $95,000 Annual Trustee share award, the number of shares of which is calculated based upon a closing price on 05/23/2018 of $15.95. Shares vested immediately upon grant. Read SEC document |
| December 30, 2017 Filed Jan 3, 2018 21:56 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 6,882 | $4.14 | $28,491.48 |
DisclosureSEC source: 0001209191-18-000996 · doc4.xml · nonDerivative · entry 2 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,446 F2 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 21:56 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | GrantCommon Stock | 17,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-000996 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,328 F1 · shares: 17,258 shares vest on 12/29/2018. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:36 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001209191-17-065438 · doc4.xml · derivative · entry 3 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:36 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 15,800 | $4.20 | $66,360.00 |
DisclosureSEC source: 0001209191-17-065438 · doc4.xml · nonDerivative · entry 2 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,070 F1 · shares: Represents 13,000 shares withheld to pay exercise price and 2,800 shares withheld to pay tax withholding obligations. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 21:36 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionCommon Stock | 20,000 | $2.73 | $54,600.00 |
DisclosureSEC source: 0001209191-17-065438 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:45 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | SaleCommon Shares of Beneficial Interest | 1,824 | $16.82 | $30,679.68 |
DisclosureSEC source: 0001209191-17-049365 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,948 Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:29 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001209191-17-039831 · doc4.xml · derivative · entry 3 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:29 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 13,980 | $5.47 | $76,470.60 |
DisclosureSEC source: 0001209191-17-039831 · doc4.xml · nonDerivative · entry 2 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,870 F1 · shares: Represents shares withheld to pay exercise price and withholding tax obligations. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:29 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionCommon Stock | 15,000 | $4.85 | $72,750.00 |
DisclosureSEC source: 0001209191-17-039831 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2017 Filed May 19, 2017 18:09 UTC | BRANDYWINE REALTY TRUST BDN · Entity 5445 | GrantCommon Shares of Beneficial Interest | 4,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-033864 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,772 F1 · security: These shares reflect the $70,000 Annual Trustee share award, the number of shares of which is calculated based upon a closing price on 05/18/2017 of $17.23. Shares will vest ratably over three years: 1/3 on May 18, 2018; 1/3 on May 18, 2019 and 1/3 on May 18, 2020. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:36 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 10,664 | $5.35 | $57,052.40 |
DisclosureSEC source: 0001209191-17-000962 · doc4.xml · nonDerivative · entry 2 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,850 F2 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:36 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | GrantCommon Stock | 17,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000962 · doc4.xml · nonDerivative · entry 1 Fowler Wyche · CIK 0001301268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,514 F1 · shares: 17,204 shares vest on 12/30/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.